Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine. The ...
A digital therapeutic (DTx) that aims to treat negative symptoms of schizophrenia, like apathy and social withdrawal, has hit the target in a phase 3 trial. The smartphone-based CT-155 app, ...
I placed an online order for 1 item but immediately got several pop up screens indicating I had also purchased other items. I felt that I was being scammed so I immediately requested a cancellation ...